朗姿股份(002612) - 朗姿股份调研活动信息
LANCYLANCY(SZ:002612)2022-12-03 08:50

Group 1: Company Overview and Strategy - The company is focused on building a "pan-fashion industry interconnected ecosystem" to strengthen its position in the fashion women's wear sector and expand into medical beauty and children's products [4][5]. - The company aims to leverage the rise of new retail formats and innovate its business model to enhance competitiveness [4]. Group 2: Business Performance - In the first three quarters of 2020, the women's wear segment generated revenue of 860 million CNY, with a monthly narrowing decline [5]. - The online sales during the "Double 11" shopping festival reached 120 million CNY, representing a 89% increase compared to the previous year [5]. - The children's wear segment reported revenue of 353.83 million CNY in the first half of 2020, with a slight decline compared to the same period last year [6]. Group 3: Medical Beauty Segment - The medical beauty segment achieved revenue of 598.19 million CNY and a net profit of 46.99 million CNY in the first three quarters of 2020 [6][7]. - The company operates 18 medical beauty institutions, including 5 hospitals, with a focus on expanding in first- and second-tier cities [6][9]. - The medical beauty market in China is projected to grow from 224.5 billion CNY in 2018 to 315 billion CNY in 2020, with an annual growth rate exceeding 20% [8]. Group 4: Market Position and Future Outlook - The penetration rate of medical beauty services among women aged 18-40 in China is 7.4%, compared to 42% in South Korea, indicating significant growth potential [8]. - The company plans to expand its medical beauty business through both organic growth and acquisitions, focusing on core cities in central and western China in the short term [11]. - The company emphasizes the importance of quality and compliance in its medical beauty services to build consumer trust [10][12].